 |
|
|
| FAR Issue Vol. 44/No. 214 | Section IV | |
| Issue Date: November 1, 2018 | ||
|
| Total number of notices in Section IV: 1 |
| Notice / Adopted |
Description | ID | Publish Date |
|
|---|---|---|---|---|
|
Rescheduling of a Drug Product in Finished Dosage Formulation That Has Been Approved by the U.S. Food and Drug Administration That Contains Cannabidiol (2-[1R-3-methyl-6R-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol) .... | 21109642 |
11/1/2018 Vol. 44/214 |
|